Lithuanian Prostate Diagnostics Implementation Guide
0.0.1 - ci-build
Lithuanian Prostate Diagnostics Implementation Guide
0.0.1 - ci-build
Lithuanian Prostate Diagnostics Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-prostate/ and changes regularly. See the Directory of published versions
| Draft nuo 2025-03-24 |
{
"resourceType" : "ConceptMap",
"id" : "conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate",
"language" : "lt",
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"lt\" lang=\"lt\"><hr/><p><b>Lithuanian</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: ConceptMap conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate</b></p><a name=\"lt-conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate\"> </a><a name=\"lt-hcconceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Language: en</p></div><p>Mapping from (not specified) to (not specified)</p><br/><p><b>Group 1 </b>Mapping from <a href=\"CodeSystem-prostate-pathology-questionnaire-item.html\">Prostate pathology ESPBI Questionnaire item (linkId)version: 0.0.1)</a> to <a href=\"CodeSystem-prostate-fhir-mapping-target.html\">Prostate questionnaire → FHIR mapping target (illustrative)version: 0.0.1)</a></p><table class=\"grid\"><tr><td><b>Source Code</b></td><td><b>Relationship</b></td><td><b>Target Code</b></td><td><b>Comment</b></td></tr><tr><td>bioptate-length-mm (Bioptate length (mm))</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>specimen-dimension-or-measurement (Specimen / Observation specimen measurement (TumorMeasurementLtLab, gross))</td><td>Specimen dimension or Observation-observation-specimen-measurement-example (LT Lab).</td></tr><tr><td>specimen-quality (Quality of materials)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>specimen-adequacy-finding (Observation: specimen adequacy (LT Lab))</td><td>Observation-observation-specimen-adequacy-example (LT Lab); map answerCoding to SNOMED finding codes from national spec.</td></tr><tr><td>treatment-effect (Treatment effect on tumour)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-tumor-treatment-effect (Observation: tumor treatment effect (TumorObservableLtLab))</td><td>TumorObservableLtLab or narrative in DiagnosticReport; map radiotherapy/hormone SNOMED from spreadsheet.</td></tr><tr><td>histological-type (Primary histological type)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>condition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O))</td><td>Condition.code / morphology; Condition-condition-prostate-cancer-example (LT Lab) for integrated staging.</td></tr><tr><td>histological-comment (Histological type comment)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>condition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O))</td><td>Condition.note or Observation.note; complements histological-type.</td></tr><tr><td>isup-grade-group</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-gleason-isup-prostate (GleasonIsupObservationLtProstate + ProstateIsupGradeGroupVS)</td><td>GleasonIsupObservationLtProstate + ValueSet prostate-isup-grade-group. Example: Observation-observation-prostate-gleason-gradegroup-example.</td></tr><tr><td>idc-status (Intraductal carcinoma (IDC))</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-tumor-microscopic-idc (TumorObservableLtLab / morphology for IDC)</td><td>TumorObservableLtLab / morphology Observation; national form has additional IDC sub-questions.</td></tr><tr><td>cribriform-status (Cribriform glands)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-tumor-microscopic-cribriform (TumorObservableLtLab / morphology for cribriform)</td><td>TumorObservableLtLab or structured finding Observation.</td></tr><tr><td>pattern4-pct-band (Pattern 4 quantity (percent band))</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-pattern4-percent (Observation: Pattern 4 percent band (lab tumour measurement patterns))</td><td>TumorMeasurementLtLab or lab tumour Observation; dr-prostate has finer bands than this Questionnaire.</td></tr><tr><td>tumor-percent-in-biopsy (Tumour percentage in biopsy tissue)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-tumor-burden-percent (Observation: tumour percentage in biopsy tissue)</td><td>Quantitative tumour assessment row in dr-prostate; map to Observation ratio or coded category.</td></tr><tr><td>periprostatic-fat-invasion</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-periprostatic-invasion (Observation: periprostatic fat / seminal vesicle invasion (LT Lab tumour findings))</td><td>NeoplasmInvasionLtProstate (imaging) vs microscopic finding in pathology Observation; use LT Lab tumour findings for biopsy.</td></tr><tr><td>perineural-invasion</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-perineural-invasion (Observation: perineural invasion finding (LT Lab tumour findings))</td><td>SNOMED 369731000 (present), 370051000 (absent), 385001000 (not identified), 396393005 (indeterminate); use LT Lab tumour findings.</td></tr><tr><td>lymphovascular-invasion (Lymphatic and/or vascular tumour invasion)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#related-to\" title=\"related-to\">is related to</a></td><td>observation-lymphovascular-invasion (Observation: lymphovascular invasion finding (LT Lab tumour findings))</td><td>SNOMED 385414009 Lymphatic (small vessel) tumor invasion finding; use LT Lab tumour findings for biopsy microscopic assessment.</td></tr></table></div>"
},
"url" : "https://hl7.lt/fhir/prostate/ConceptMap/prostate-pathology-questionnaire-to-fhir",
"version" : "0.1.0",
"name" : "ProstatePathologyQuestionnaireToFhir",
"title" : "Prostate pathology Questionnaire items to FHIR mapping",
"status" : "draft",
"experimental" : true,
"date" : "2025-03-24",
"publisher" : "Lithuanian Medical Library",
"contact" : [
{
"name" : "Lithuanian Medical Library",
"telecom" : [
{
"system" : "url",
"value" : "https://medicinosnk.lt"
},
{
"system" : "email",
"value" : "info@medicinosnk.lt"
}
]
}
],
"description" : "Maps dr-prostate-aligned pathology Questionnaire linkIds to LT Lab and LT Prostate Gleason/ISUP patterns.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "LT"
}
]
}
],
"group" : [
{
"source" : "https://tx.hl7.lt/fhir/CodeSystem/prostate-pathology-questionnaire-item|0.0.1",
"target" : "https://tx.hl7.lt/fhir/CodeSystem/prostate-fhir-mapping-target|0.0.1",
"element" : [
{
"code" : "bioptate-length-mm",
"display" : "Bioptate length (mm)",
"target" : [
{
"code" : "specimen-dimension-or-measurement",
"relationship" : "related-to",
"comment" : "Specimen dimension or Observation-observation-specimen-measurement-example (LT Lab)."
}
]
},
{
"code" : "specimen-quality",
"display" : "Quality of materials",
"target" : [
{
"code" : "specimen-adequacy-finding",
"relationship" : "related-to",
"comment" : "Observation-observation-specimen-adequacy-example (LT Lab); map answerCoding to SNOMED finding codes from national spec."
}
]
},
{
"code" : "treatment-effect",
"display" : "Treatment effect on tumour",
"target" : [
{
"code" : "observation-tumor-treatment-effect",
"relationship" : "related-to",
"comment" : "TumorObservableLtLab or narrative in DiagnosticReport; map radiotherapy/hormone SNOMED from spreadsheet."
}
]
},
{
"code" : "histological-type",
"display" : "Primary histological type",
"target" : [
{
"code" : "condition-morphology-prostate",
"relationship" : "related-to",
"comment" : "Condition.code / morphology; Condition-condition-prostate-cancer-example (LT Lab) for integrated staging."
}
]
},
{
"code" : "histological-comment",
"display" : "Histological type comment",
"target" : [
{
"code" : "condition-morphology-prostate",
"relationship" : "related-to",
"comment" : "Condition.note or Observation.note; complements histological-type."
}
]
},
{
"code" : "isup-grade-group",
"display" : "ISUP grade group",
"target" : [
{
"code" : "observation-gleason-isup-prostate",
"relationship" : "related-to",
"comment" : "GleasonIsupObservationLtProstate + ValueSet prostate-isup-grade-group. Example: Observation-observation-prostate-gleason-gradegroup-example."
}
]
},
{
"code" : "idc-status",
"display" : "Intraductal carcinoma (IDC)",
"target" : [
{
"code" : "observation-tumor-microscopic-idc",
"relationship" : "related-to",
"comment" : "TumorObservableLtLab / morphology Observation; national form has additional IDC sub-questions."
}
]
},
{
"code" : "cribriform-status",
"display" : "Cribriform glands",
"target" : [
{
"code" : "observation-tumor-microscopic-cribriform",
"relationship" : "related-to",
"comment" : "TumorObservableLtLab or structured finding Observation."
}
]
},
{
"code" : "pattern4-pct-band",
"display" : "Pattern 4 quantity (percent band)",
"target" : [
{
"code" : "observation-pattern4-percent",
"relationship" : "related-to",
"comment" : "TumorMeasurementLtLab or lab tumour Observation; dr-prostate has finer bands than this Questionnaire."
}
]
},
{
"code" : "tumor-percent-in-biopsy",
"display" : "Tumour percentage in biopsy tissue",
"target" : [
{
"code" : "observation-tumor-burden-percent",
"relationship" : "related-to",
"comment" : "Quantitative tumour assessment row in dr-prostate; map to Observation ratio or coded category."
}
]
},
{
"code" : "periprostatic-fat-invasion",
"display" : "Periprostatic fat invasion",
"target" : [
{
"code" : "observation-periprostatic-invasion",
"relationship" : "related-to",
"comment" : "NeoplasmInvasionLtProstate (imaging) vs microscopic finding in pathology Observation; use LT Lab tumour findings for biopsy."
}
]
},
{
"code" : "perineural-invasion",
"display" : "Perineural invasion",
"target" : [
{
"code" : "observation-perineural-invasion",
"relationship" : "related-to",
"comment" : "SNOMED 369731000 (present), 370051000 (absent), 385001000 (not identified), 396393005 (indeterminate); use LT Lab tumour findings."
}
]
},
{
"code" : "lymphovascular-invasion",
"display" : "Lymphatic and/or vascular tumour invasion",
"target" : [
{
"code" : "observation-lymphovascular-invasion",
"relationship" : "related-to",
"comment" : "SNOMED 385414009 Lymphatic (small vessel) tumor invasion finding; use LT Lab tumour findings for biopsy microscopic assessment."
}
]
}
]
}
]
}